Safety of trivalent chromium complexes: No evidence for DNA damage in human HaCaT keratinocytes

Free Radical Biology and Medicine

Volumn 42, Issue 12, 2007, Pages 1759-1765

  Hininger, Isabelle ^a   Benaraba, Rachida ^a   Osman, Mireille ^a   Faure, Henri ^a   Marie Roussel, Anne ^a   Anderson, Richard A ^b  

^a UNIV GRENOBLE ALPES   (France)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Cr(III) genotoxicity; DNA damage; Free radicals; Oxidative stress; Trivalent chromium

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 8 HYDROXYDEOXYGUANOSINE; CHROMIC ACID; CHROMIUM CHLORIDE; CHROMIUM DERIVATIVE; CHROMIUM DICHROMATE; CHROMIUM HISTIDINATE; CHROMIUM PICOLINATE; DICHROMATE SODIUM; DNA; HYDROGEN PEROXIDE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRAIN; CELL STRESS; CELL VIABILITY; COMET ASSAY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DIET SUPPLEMENTATION; DNA DAMAGE; GENOTOXICITY; HUMAN; HUMAN CELL; KERATINOCYTE; LC 50; NUTRIENT; OXIDATIVE STRESS; PRIORITY JOURNAL;

CARCINOGENS, ENVIRONMENTAL; CELL SURVIVAL; CELLS, CULTURED; CHLORIDES; CHROMATES; CHROMIUM; CHROMIUM COMPOUNDS; COMET ASSAY; DEOXYGUANOSINE; DIETARY SUPPLEMENTS; DNA DAMAGE; DNA REPAIR; DRUG TOXICITY; HUMANS; HYDROGEN PEROXIDE; KERATINOCYTES; L-LACTATE DEHYDROGENASE; OXIDANTS; OXIDATION-REDUCTION; PICOLINIC ACIDS;

EID: 34249058380     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.02.034     Document Type: Article

References (47)

1. Althuisfs M.D., Jordan N.E., Ludington E.A., and Wittes J.T. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am. J. Clin. Nutr. 76 (2002) 148-155
2. Anderson R.A. Effects of chromium on body composition and weight loss. Nutr. Rev. 56 (1998) 266-270
3. Anderson R.A. Chromium, glucose intolerance and diabetes. J. Am. Coll. Nutr. 17 (1998) 548-555
4. Anderson R.A. Chromium and insulin sensitivity. Nutr. Res. Rev. 16 (2003) 267-275
5. Anderson R.A., Bryden N.A., and Polansky M.M. Lack of toxicity of chromium chloride and chromium picolinate in rats. J. Am. Coll. Nutr. 16 (1997) 273-279
6. Anderson R.A., Polansky M.M., and Bryden N.A. Stability and absorption of chromium and absorption of chromium histidinate complexes by humans. Biol. Trace Elem. Res. 101 (2004) 211-218
7. Anderson R.A., Roussel A.M., Zouari N., Mahjoub S., Matheau J.M., and Kerkeni A. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J. Am. Coll. Nutr. 20 (2001) 212-218
8. Bagchi D., Bagchi M., Balmoori J., Ye X., and Stohs S.J. Comparative induction of oxidative stress in cultured J774A.1 macrophage cells by chromium picolinate and chromium nicotinate. Res. Commun. Mol. Pathol. Pharmacol. 97 (1997) 335-346
9. Bagchi D., Stohs S.J., Downs B.W., Bagchi M., and Preuss H.G. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180 (2002) 5-22
10. Balamurugan K., Rajaram R., and Ramasami T. Caspase-3: its potential involvement in Cr(III)-induced apoptosis of lymphocytes. Mol. Cell. Biochem. 259 (2004) 43-51
11. Balamurugan K., Rajaram R., Ramasami T., and Narayanan S. Chromium(III)-induced apoptosis of lymphocytes: death decision by ROS and Src-family tyrosine kinases. Free Radic. Biol. Med. 33 (2002) 1622-1640
12. Biedermann K.A., and Landolph J.R. Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis, and anchorage independence in diploid human fibroblasts. Cancer Res. 50 (1990) 7835-7842
13. Blankert S.A., Coryell V.H., Picard B.T., Wolf K.K., Lomas R.E., and Stearns D.M. Characterization of nonmutagenic Cr(III)-DNA interactions. Chem. Res. Toxicol. 16 (2003) 847-854
14. Blasiak J., and Kowalik J. A comparison of the in vitro genotoxicity of tri- and hexavalent chromium. Mutat. Res. 469 (2000) 135-145
15. Bridgewater L.C., Manning F.C., Woo E.S., and Patierno S.R. DNA polymerase arrest by adducted trivalent chromium. Mol. Carcinog. 9 (1994) 122-133
16. Cefalu W.T., and Hu F.B. Role of chromium in human health and in diabetes. Diabetes Care 27 (2004) 2741-2751
17. Cheng H.H., Lai M.H., Hou W.C., and Huang C.L. Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. J. Agric. Food Chem. 52 (2004) 1385-1389
18. Ding, M.; Shi, X. Molecular mechanisms of Cr(VI)-induced carcinogenesis. Mol. Cell. Biochem. 234-235:293-300; 2002.
19. Ermolli M., Menne C., Pozzi G., Serra M.A., and Clerici L.A. Nickel, cobalt and chromium-induced cytotoxicity and intracellular accumulation in human HaCaT keratinocytes. Toxicology 159 (2001) 23-31
20. Gedik C.M., and Collins A. Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB J. 19 (2005) 82-84
21. Hininger I., Chollat-Namy A., Sauvaigo S., Osman M., Faure H., Cadet J., Favier A., and Roussel A.M. Assessment of DNA damage by comet assay on frozen total blood: method and evaluation in smokers and non-smokers. Mutat. Res. 558 (2004) 75-80
22. Horowitz S.B., and Finley B.L. Setting health-protective soil concentrations for dermal contact allergens: a proposed methodology. Regul. Toxicol. Pharmacol. 19 (1994) 31-47
23. Jain S.K., and Kannan K. Chromium chloride inhibits oxidative stress and TNF-α secretion caused by exposure to high glucose in cultured U937 monocytes. Biochem. Biophys. Res. Commun. 289 (2001) 687-691
24. Jain S.K., and Kannan K. Chromium chloride inhibits oxidative stress and TNF-α secretion caused by exposure to high glucose in cultured U937 monocytes. Biochem. Biophys. Res. Commun. 289 (2001) 687-691
25. Kato I., Vogelman J.H., Dilman V., Karkoszka J., Frenkel K., Durr N.P., Orentreich N., and Toniolo P. Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uracil. Eur. J. Epidemiol. 14 (1998) 621-626
26. Kirpnick-Sobol Z., Reliene R., and Schiestl R.H. Carcinogenic Cr(VI) and the nutritional supplement Cr(III) induce DNA deletions in yeast and mice. Cancer Res. 66 (2006) 3480-3484
27. Lee A.J., Hodges N.J., and Chipman J.K. Modified comet assay as a biomarker of sodium dichromate-induced oxidative DNA damage: optimization and reproducibility. Biomarkers 9 (2004) 103-115
28. Martin J., Wang Z.Q., Zhang X.H., Wachtel D., Volaufova J., Matthews D.E., and Cefalu W.T. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 29 (2006) 1826-1832
29. O'Brien T.J., Ceryak S., and Patierno S.R. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat. Res. 533 (2003) 3-36
30. Patierno S.R., Banh D., and Landolph J.R. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Cancer Res. 48 (1988) 5280-5288
31. Pittler M.H., Stevinson C., and Ernst E. Chromium picolinate for reducing body weight: meta-analysis of randomized trials. Int.J. Obes. Relat. Metab. Disord. 27 (2003) 522-529
32. Plaper A., Jenko-Brinovec S., Premzl A., Kos J., and Raspor P. Genotoxicity of trivalent chromium in bacterial cells: possible effects on DNA topology. Chem. Res. Toxicol. 15 (2002) 943-949
33. Qi W., Reiter R.J., Tan D.X., Garcia J.J., Manchester L.C., Karbownik M., and Calvo J.R. Chromium(III)-induced 8-hydroxydeoxyguanosine in DNA and its reduction by antioxidants: comparative effects of melatonin, ascorbate, and vitamin E. Environ. Health Perspect. 108 (2000) 399-402
34. Rodriguez H., and Akman S.A. Mapping oxidative DNA damage at nucleotide level. Free Radic. Res. 29 (1998) 499-510
35. Shrivastava H.Y., Ravikumar T., Shanmugasundaram N., Babu M., and Unni N.B. Cytotoxicity studies of chromium(III) complexes on human dermal fibroblasts. Free Radic. Biol. Med. 38 (2005) 58-69
36. Singh N.P., McCoy M.T., Tice R.R., and Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175 (1988) 184-191
37. Slesinski R.S., Clarke J.J., RH C.S., and Gudi R. Lack of mutagenicity of chromium picolinate in the hypoxanthine phosphoribosyltransferase gene mutation assay in Chinese hamster ovary cells. Mutat. Res. 585 1-2 (2005) 86-95
38. Speetjens J.K., Collins R.A., Vincent J.B., and Woski S.A. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chem. Res. Toxicol. 12 (1999) 483-487
39. Stearns D.M., Belbruno J.J., and Wetterhahn K.E. A prediction of chromium(III) accumulation in humans from chromium dietary supplements. FASEB J. 9 (1995) 1650-1657
40. Stearns D.M., Kennedy L.J., Courtney K.D., Giangrande P.H., Phieffer L.S., and Wetterhahn K.E. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry 34 (1995) 910-919
41. Stearns D.M., Silveira S.M., Wolf K.K., and Luke A.M. Chromium(III) tris(picolinate) is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells. Mutat. Res. 513 (2002) 135-142
42. Stohs S.J., Bagchi D., Hassoun E., and Bagchi M. Oxidative mechanisms in the toxicity of chromium and cadmium ions. J. Environ. Pathol. Toxicol. Oncol. 20 (2001) 77-88
43. Tezuka M., Momiyama K., Edano T., and Okada S. Protective effect of chromium(III) on acute lethal toxicity of carbon tetrachloride in rats and mice. J. Inorg. Biochem. 42 (1991) 1-8
44. Tsou T.C., and Yang J.L. Formation of reactive oxygen species and DNA strand breakage during interaction of chromium(III) and hydrogen peroxide in vitro: evidence for a chromium(III)-mediated Fenton-like reaction. Chem. Biol. Interact. 102 (1996) 133-153
45. Vincent J.B. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med. 33 (2003) 213-230
46. Whittaker P., San R.H., Clarke J.J., Seifried H.E., and Dunkel V.C. Mutagenicity of chromium picolinate and its components in Salmonella typhimurium and L5178Y mouse lymphoma cells. Food Chem. Toxicol. 43 (2005) 1619-1625
47. Zhitkovich A., Quievryn G., Messer J., and Motylevich Z. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI). Environ. Health Perspect. 110 Suppl. 5 (2002) 729-731